Yet another #biotech #breakout - Latest quarter showed a +290% earnings improvement. This #biopharma has a $4B market cap. Watching, not buying.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
